Fact CheckerSign in

NCT07387237Completed

Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

Multigene germeline panel test in gastric cancer patients

Status (registry)
Completed
Study type
Observational
Enrollment
51 (actual)
First submitted
1 Oct 2025
Start date
20 Sept 2023
Primary completion date
1 Aug 2025
Lead sponsor
Unidade Local De Saúde Do Norte Alentejano
NCT number
NCT07387237

What you commit to

  • Study type: Observational
  • Participants enrolled: 51
  • From 20 Sept 2023 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • All patients who met eligibility and inclusion criteria were included in the study;
  • Patients without a definitive genetic report or with incomplete clinical data for key study variables were excluded.

Who the study is looking for

  • Eligible participants were adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025;
  • Ability to understand Portuguese and/or English;
  • Ability to provide valid informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Unidade Local de Saúde do Alto Alentejo
Coordinator of this site? Confirm its status		PortalegrePortugalUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.